Essex Bio-Technology Limited

HK$2.02As of Sun 8 Nov 2026, 12:00 UTC
HKEX:1061Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR (3.04%)
Div yield 6.93%
ROE 11.01%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.03
PE TTM 4.315
TSR TTM (50.85%)
Mkt cap HK$1.141B
ROIC 12.15%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.10
3.96%
(45.08%)
Hold 10|0|12|9|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.05
0.05
0.06
0.06
12.28%
12.83%
25.75%
40.95%
Revenue$M
63.10
62.97
61.47
62.57
4.65%
(1.44%)
(4.50%)
(0.36%)
Peers (US$145.6M)
Cap (US$)
PE
167.8M
6.517x
145.5M
—
Capital
TTM
5Y
10Y
Leveragex
0.766
2.188
2.186
EBIT/Intx
2.040
0.164
0.154
Own earn%
10.25
92.70
90.18
Sh yield%
14.40
32.02
35.32
Owners
Insiders/Inst%
2.38
40.26
Short interest%
1.87
SBC / revenue%
5.66
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
27–33
$1 testx
—
Incr. ROIC%
4